% | $
Quotes you view appear here for quick access.

Enanta Pharmaceuticals, Inc. Message Board

  • kat9089 kat9089 Dec 18, 2013 7:22 PM Flag

    i still see 25 in its near future, chart, and obviously there were panic today but bottom

    was not in and also no capitulation to say there was a bottom. jmho

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • defilip1 Jan 16, 2014 4:25 PM Flag

      Although the stock is bouncing around a bit, the general trend is up. My guess is the overall market optimism for Hep C drugs in general will continue to have upwards pressure on ENTA $ / sh.

      Sentiment: Strong Buy

    • charts have no meaning. its like analyzing bunch of random data. the only thing that moves a stock and increases/decreases its market cap is useful information and not random day to day stock movement. I've never seen a chartiest who didn't talk from both side his mouth.

    • Here's the bottom line: ABBV should be the company taking the enormous hit, not ENTA. Instead of getting 3-4 billion in revenues, now it might be 1-2 billion. But ABBV will get at least that, because they will start a price war with GILD, which has their drug priced at $84,000. ABBV will come in substantially below that, and insurance companies don't care that you need to take 4 pills instead of 1 - the cure rate is the same. So if ABBV gets 2 bill, then ENTA will get about 300 mill, with no value on the rest of their pipeline. So I think the price is going to drift back into the $33 range, and will get back up to $35-$38 after approvals. Remember, they got breakthrough designation so there shouldn't be any holdups getting the drug approved.

29.20-0.57(-1.91%)Apr 29 4:00 PMEDT